Co-Diagnostics Reports Solid First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- Wall Street rallies as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Co-Diagnostics (CODX) Tops Q1 EPS by 17c
May 12, 2022 4:12 PM EDTCo-Diagnostics (NASDAQ: CODX) reported Q1 EPS of $0.34, $0.17 better than the analyst estimate of $0.17. Revenue for the quarter came in at $22.7 million versus the consensus estimate of $20.17 million.
For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.
... More